Concert Pharmaceuticals, Inc.
USD8.37
+0.00 (+0.00%)
CEO
Roger D. Tung
IPO Date
2014-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.38
Prev. Close
$8.37
Day Low
$8.35
Day High
$8.55
52W Low
$2.72
52W High
$8.55
| -5.3 |
| 31 Dec 2019 | FY | 100.0% | -7180.0% | -76.2% | -56.3% | 0.16 | 6.77 | -2.8 |
| 31 Dec 2018 | FY | 100.0% | -533.3% | -33.4% | -29.1% | 0.00 | 20.59 | -5.2 |
| 31 Dec 2017 | FY | 100.0% | 66.5% | 48.7% | 45.2% | 0.00 | 31.92 | 6.1 |
| 31 Dec 2016 | FY | 100.0% | -29149.4% | -59.3% | -50.5% | 0.00 | 17.55 | -4.5 |
| 31 Dec 2015 | FY | 100.0% | 36.2% | 18.5% | 16.5% | 0.00 | 21.75 | 16.6 |
| 31 Dec 2014 | FY | 100.0% | -369.6% | -57.8% | -37.5% | 0.13 | 4.39 | -6.7 |
| 31 Dec 2013 | FY | 100.0% | -23.8% | 5.4% | -15.2% | -0.14 | 2.14 | -26.3 |
| 31 Dec 2012 | FY | 100.0% | -159.1% | 19.2% | -61.7% | -0.19 | 3.65 | -7.8 |
| -2.0 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -51.5% | -30.5% | 0.19 | 7.61 | -0.8 |
| 31 Dec 2021 | Q4 | 100.0% | 81909.3% | 20.1% | 13.7% | 0.13 | 9.33 | 1.2 |
| 30 Sept 2021 | Q3 | 100.0% | -4913.1% | -26.9% | -20.8% | 0.15 | 9.39 | -1.0 |
| 30 Jun 2021 | Q2 | 100.0% | 16.9% | 4.4% | 3.6% | 0.13 | 15.34 | 6.6 |
| 31 Mar 2021 | Q1 | 100.0% | -453380.0% | -19.9% | -16.2% | 0.14 | 14.92 | -1.9 |
| 31 Dec 2020 | Q4 | 100.0% | -319857.1% | -17.1% | -14.1% | 0.12 | 14.02 | -4.6 |
| 30 Sept 2020 | Q3 | 100.0% | -1259.7% | -14.8% | -12.3% | 0.13 | 18.51 | -4.1 |
| 30 Jun 2020 | Q2 | 100.0% | -203.4% | -9.0% | -7.6% | 0.11 | 16.07 | -6.0 |